| Cash Flow for Labopharm Inc. (DDSS) | | | | | | | Cash Flow | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | | | Net Income | (36,827) | (20,486) | (28,664) | (22,651) | | Depreciation & Amortization | 1,741 | 1,300 | 1,310 | 1,267 | | Deferred Income Taxes | 18 | (115) | - | - | | Operating Losses | - | - | 1,636 | 1,479 | | Extraordinary Losses | - | - | - | - | | | Decrease in Receivables | 1,959 | (4,156) | (125) | - | | Decrease in Inventories | 2,429 | (2,660) | (1,881) | - | | Decrease in Other Current Assets | - | - | - | - | | Increase in Payables | 68 | (521) | 2,700 | - | | Increase in Other Current Liabilities | - | - | 24,185 | - | | Decrease in Other Working Capital | (3,122) | (4,628) | - | - | | Other Non-Cash Items | 5,942 | 1,441 | - | 550 | | Net Cash from Continuing Operations | (27,366) | (30,125) | (894) | (19,237) | | Net Cash from Discontinued Operations | - | - | - | - | | Cash from Operating Activities | (27,366) | (30,125) | (894) | (19,237) | | | | Sale of Property, Plant, Equipment | - | - | - | - | | Sale of Short Term Investments | 100,031 | 30,039 | 22,910 | 34,552 | | | Purchase of Property, Plant, Equipment | (2,361) | (2,641) | (874) | (833) | | Acquisitions | - | - | - | - | | Purchase of Short Term Investments | (73,570) | (91,227) | (17,576) | (36,292) | | Other Investment Changes, Net | - | - | - | (156) | | Cash from Investing Activities | 24,100 | (63,830) | 4,460 | (2,729) | | | Issuance of Debt | 14,214 | - | 9,963 | - | | Issuance of Capital Stock | 771 | 98,428 | 2,428 | 25,680 | | | Repayment of Debt | (7,122) | (2,879) | (115) | (143) | | Repurchase of Capital Stock | - | (7,932) | - | (1,830) | | Payment of Cash Dividends | - | - | - | - | | Other Financing Charges, Net | (25) | - | (408) | - | | Cash from Financing Activities | 7,839 | 87,617 | 11,868 | 23,707 | | | | Effect of Exchange Rate Changes | (1,099) | 706 | (409) | - | | Net Change in Cash | 3,475 | (5,631) | 15,025 | 1,741 | | | Cash at Beginning of Year | 13,817 | 17,410 | 2,415 | 600 | | Cash at End of Period | 17,291 | 11,779 | 17,440 | 2,341 | | | |
